BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30581499)

  • 1. Differential Gene Expression Profile of Renin-Angiotensin System in the Left Atrium in Mitral Regurgitation Patients.
    Liu WH; Fang YN; Wu CC; Chen MC; Chang JP; Lin YS; Pan KL; Ho WC; Chang TH; Huang YK; Fang CY; Chen CJ; Lee WC
    Dis Markers; 2018; 2018():6924608. PubMed ID: 30581499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling regulatory mechanisms of atrial remodeling of mitral regurgitation pigs by gene expression profiling analysis: role of type I angiotensin II receptor antagonist.
    Chen MC; Chang JP; Chang TH; Hsu SD; Huang HD; Ho WC; Wang FS; Hsiao CC; Liu WH
    Transl Res; 2015 May; 165(5):599-620. PubMed ID: 25500755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the gene expression profile of peroxisome proliferator-activated receptor signaling pathway in the left atria of patients with mitral regurgitation.
    Chen MC; Chang JP; Lin YS; Pan KL; Ho WC; Liu WH; Chang TH; Huang YK; Fang CY; Chen CJ
    J Transl Med; 2016 Jun; 14(1):157. PubMed ID: 27250500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
    Peltonen T; Näpänkangas J; Ohtonen P; Aro J; Peltonen J; Soini Y; Juvonen T; Satta J; Ruskoaho H; Taskinen P
    Atherosclerosis; 2011 May; 216(1):35-43. PubMed ID: 21316680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Regulatory Mechanisms of Atrial Myocyte Hypertrophy of Mitral Regurgitation through Gene Expression Profiling Analysis: Role of NFAT in Cardiac Hypertrophy.
    Chang TH; Chen MC; Chang JP; Huang HD; Ho WC; Lin YS; Pan KL; Huang YK; Liu WH; Wu CC
    PLoS One; 2016; 11(12):e0166791. PubMed ID: 27907007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer.
    Mehranfard D; Perez G; Rodriguez A; Ladna JM; Neagra CT; Goldstein B; Carroll T; Tran A; Trivedi M; Speth RC
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():9987115. PubMed ID: 34285715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating and local renin-angiotensin-aldosterone system express differently in atrial fibrillation patients with different types of mitral valvular disease.
    Qian Y; Liu Y; Tang H; Zhou W; Jiang L; Li Y; Li N; Li M; Xiao X
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):204-11. PubMed ID: 23077077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
    Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
    Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miR-148b-3p and miR-409-3p as biomarkers for heart failure in patients with mitral regurgitation.
    Chen MC; Chang TH; Chang JP; Huang HD; Ho WC; Lin YS; Pan KL; Liu WH; Huang YK
    Int J Cardiol; 2016 Nov; 222():148-154. PubMed ID: 27505319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mineralocorticoid receptor gene disruption on the components of the renin-angiotensin system in 8-day-old mice.
    Hubert C; Gasc JM; Berger S; Schütz G; Corvol P
    Mol Endocrinol; 1999 Feb; 13(2):297-306. PubMed ID: 9973259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system gene polymorphisms and atrial fibrillation.
    Tsai CT; Lai LP; Lin JL; Chiang FT; Hwang JJ; Ritchie MD; Moore JH; Hsu KL; Tseng CD; Liau CS; Tseng YZ
    Circulation; 2004 Apr; 109(13):1640-6. PubMed ID: 15023884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation.
    Kang DH; Park SJ; Shin SH; Hong GR; Lee S; Kim MS; Yun SC; Song JM; Park SW; Kim JJ
    Circulation; 2019 Mar; 139(11):1354-1365. PubMed ID: 30586756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog.
    Perry GJ; Wei CC; Hankes GH; Dillon SR; Rynders P; Mukherjee R; Spinale FG; Dell'Italia LJ
    J Am Coll Cardiol; 2002 Apr; 39(8):1374-9. PubMed ID: 11955858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renin-angiotensin system in mitral regurgitation: a typical example of tissue activation.
    Dell'Italia LJ
    Curr Cardiol Rep; 2002 Mar; 4(2):97-103. PubMed ID: 11827631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta1-adrenergic receptor blockade attenuates angiotensin II-mediated catecholamine release into the cardiac interstitium in mitral regurgitation.
    Tallaj J; Wei CC; Hankes GH; Holland M; Rynders P; Dillon AR; Ardell JL; Armour JA; Lucchesi PA; Dell'Italia LJ
    Circulation; 2003 Jul; 108(2):225-30. PubMed ID: 12847066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the renin-angiotensin system (RAS) in BeWo and HTR-8/SVneo trophoblast cell lines.
    Wang Y; Pringle KG; Chen YX; Zakar T; Lumbers ER
    Placenta; 2012 Aug; 33(8):634-9. PubMed ID: 22647832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial apoptotic pathway activation in the atria of heart failure patients due to mitral and tricuspid regurgitation.
    Chang JP; Chen MC; Liu WH; Lin YS; Huang YK; Pan KL; Ho WC; Fang CY; Chen CJ; Chen HC
    Exp Mol Pathol; 2015 Aug; 99(1):65-73. PubMed ID: 26004742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor type 1 is upregulated in atrial tissue of patients with rheumatic valvular disease with atrial fibrillation.
    Cong H; Li X; Ma L; Jiang H; Mao Y; Xu M
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):298-304. PubMed ID: 20080265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal sex affects expression of renin-angiotensin system components in term human decidua.
    Wang Y; Pringle KG; Sykes SD; Marques FZ; Morris BJ; Zakar T; Lumbers ER
    Endocrinology; 2012 Jan; 153(1):462-8. PubMed ID: 22045662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in pediatric patients with mitral valve regurgitation-case-control study and review of the literature.
    Knirsch W; Tlach L; Stambach D; Bauersfeld U
    Congenit Heart Dis; 2010; 5(3):278-84. PubMed ID: 20576047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.